Screening for Endometrial Abnormalities in Overweight and Obese Women
Completed · Not applicable
Conditions studied: Endometrial Cancer
In brief
The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women. There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions in overweight and/or obese women. Prevention, diagnosis and treatment of endometrial cancer and its precursor lesions in overweight and/or obese women offers substantial health benefits.
Key facts
- Study ID
- NCT01922778
- Run by
- St. Luke's-Roosevelt Hospital Center
- People needed
- 303
- Starts
- 2013-09-01
- Expected to finish
- 2016-03-31
- Last updated by the study team
- 2017-07-21
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Have BMI ≥25.
- Be patients of the St. Luke's and Roosevelt Gynecology Clinics and Faculty Practices OR be receiving bariatric surgery.
- Complete a full medical history, a detailed menstrual and/or postmenopausal bleeding history, and endometrial biopsy.
- Have a negative pregnancy test, if of childbearing age.
- Be at least 18 years of age.
- Have signed a written Informed Consent Document.
- Be willing and able to comply with the study requirements.
You may not qualify if…
- Have a BMI <25.
- Have a prior hysterectomy.
- Be pregnant or have a positive pregnancy test
- Have untreated vaginal, cervical, or adnexal infection.
- Recent treatment of STD
Where it is running
- Mount Sinai Roosevelt — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.